保险介导的妇科肿瘤诊疗差异
本文评述妇科肿瘤诊疗中由保险因素介导的差异,指出尽管治疗手段进步,参保女性仍面临可及性与可负担性障碍。约三分之一的妇科肿瘤女性从未就诊妇科肿瘤专科医生,部分医保计划缺乏网络内专科医生或国家癌症研究所认证癌症中心,医疗补助保险女性接受指南一致治疗的可能性低25%,半数参保女性治疗期间经历经济毒性。
要点
- 约三分之一妇科肿瘤女性从未就诊妇科肿瘤专科医生。
- 高达40%的Medicare Advantage计划缺乏网络内妇科肿瘤专科医生。
- 医疗补助保险女性接受指南一致治疗的可能性低25%。
核心结论
- 解决保险介导的差异对于帮助患者充分受益于领域科学进步并在妇科肿瘤诊断后茁壮成长很重要。
研究设计与样本
- 本文为评述,回顾当前关于妇科肿瘤保险介导差异的文献,并向临床医生提供诊疗障碍的教育。
主要发现
- 约三分之一的妇科肿瘤女性从未就诊妇科肿瘤专科医生。
- 高达40%的Medicare Advantage计划缺乏网络内妇科肿瘤专科医生。
- 33%的私人保险计划不包含网络内国家癌症研究所认证癌症中心,限制获得手术进步和临床试验。
- 医疗补助保险的妇科肿瘤女性接受指南一致治疗的可能性低25%。
- 参保女性中,50%在妇科肿瘤治疗期间经历经济毒性,某些Medicare参保者费用可能更高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With 102,000 new cases of gynecologic cancer, 30,000 associated deaths annually, and increasing rates of endometrial cancer, gynecologic cancer is a growing problem. Although gynecologic cancer care has advanced significantly in the past decade owing to new therapeutics and specialized training in radical surgery, even insured women face major barriers to accessing and affording quality gynecologic cancer care. This commentary reviews current literature on insurance-mediated disparities in gynecologic cancer and provides education to clinicians on barriers to care. One third of women with a gynecologic cancer never see a gynecologic oncologist. Up to 40% of Medicare Advantage plans lack an in-network gynecologic oncologist, and 33% of private insurance plans do not include an in-network National Cancer Institute-accredited cancer center, limiting access to surgical advances and clinical trials. Women with Medicaid insurance and gynecologic cancer are 25% less likely to receive guideline-concordant care. Among insured women, 50% experience financial toxicity during gynecologic cancer treatment, and costs may be even higher for certain Medicare enrollees. Addressing these insurance-mediated disparities will be important to help our patients fully benefit from the scientific advances in our field and thrive after a gynecologic cancer diagnosis.
引用
- Bodurtha Smith AJ, Pena D, Ko E, et al. Insurance-Mediated Disparities in Gynecologic Oncology Care. Obstet Gynecol. 2022. PMID: 34991133. doi:10.1097/AOG.0000000000004643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。